Faron Pharmaceuticals Oy (LON:FARN) has applied to have its shares listed on the Nasdaq First North Growth Market.
This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange.
Pending the application approval, the stock will begin trading on December 1.